4Soumerai SB McLaughlin TJ Donna S et al.老年急性心肌梗塞存活者β-阻滞剂使用过少的不良后果[J].美国医学杂志(JAMA中文版),1997,16(5):218-224.
5Siegal D, Lopez J. Trends in antihypertensive drug use in the United States : do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.JAMA, 1997,278 : 1745-1748.
6The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ( ALLHAT).JAMA, 2002, 288:2981-2997.
7Ramsey SD, Neil N, Sullivan SD, et al. An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee. J Am Board Fam Pract, 1999, 12:105-114.
8Appel LJ. The verdict from ALLHAT-thiazide diuretics are the preferred initial therapy for hypertension. JAMA, 2002,288 : 3039-3042.
9Wikstrand J, Warnold I, Olsson G, et al. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study[J]. J Am Med Assoc, 1988,259(13) : 1976-19-82.
10Kendall M,Akhlaghi S, Hughes B, et al. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol [J] .J Clin Pharmacol, 1990,30 (2Suppl) :S98-S102.
